**FOR IMMEDIATE RELEASE**

FOR IMMEDIATE RELEASE

Breaking: “Heat Advisory” or “Cash Grab-vsory”? Experts Question Profit Motive Behind Emergency Alerts as Pharma Giants Quietly Launch New “Heat Stress” Pill

NEW YORK – As a “dangerous” heat wave smothers 100 million Americans, the usual round of emergency alerts is flooding smartphones. But a growing chorus of skeptics is asking a pointed question: Who profits from the panic?

A whistleblower document leaked from a major pharmaceutical firm suggests a coordinated marketing strategy. Internal memos show the company recently pivoted production to meet “sky-high demand” for a new, expensive “heat stress prophylaxis” drug – just as the National Weather Service began issuing more frequent “excessive heat warnings” than in any previous decade.

Critics point out that the warnings, which send millions scrambling for air-conditioned spaces and bottled water, correlate neatly with record investments in climate-tech startups by the very same hedge funds that also own major media outlets.

“Look at the timing,” said Dr. Elena Vance, a former CDC meteorologist turned independent analyst. “Every time an ‘unprecedented’ heat dome forms, the stock price of air conditioning conglomerates, electrolyte beverage companies, and that new “HyperCool” pill skyrockets. It’s a predictable weather-profit cycle.”

The leaked memo allegedly suggests “capitalizing on government-issued fear” by framing a normal summer phenomenon as a “medical emergency.” Meanwhile, urban planners note that fewer people are dying from heat today than in the 1950s – before “heat advisory” was even a term.

As the advisory hits your phone again, ask yourself: is it a public health warning, or is it a revenue forecast being broadcast at 4.9 million dollars per alert?

This story is developing. Check your local forecast – and your local hedge fund’s portfolio.